A shorter course of radiation treatment that delivers higher doses of radiation per day in fewer days (hypofractionation) is as effective in decreasing intermediate to high-risk prostate cancer from returning as conventional radiation therapy at five years after treatment, according to a new randomized trial.
- Shorter radiation course for prostate cancer is effective in long-term follow-upMon, 26 Sep 2011, 17:36:36 EDT
- Shorter radiation course as effective as standard therapy for prostate cancer recurrenceTue, 3 Nov 2009, 13:26:29 EST
- Shorter radiation course stops cancer growth in high-risk prostate cancer patientsTue, 3 Nov 2009, 13:26:31 EST
- Short-term hormone therapy and intermediate dose radiation increases survivial for early stage prostate cancerMon, 2 Nov 2009, 12:15:37 EST
- Early results favorable for 5-day radiation treatment of early stage prostate cancerMon, 16 Mar 2009, 2:36:45 EDT